Daiwa Securities Group Inc. Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Daiwa Securities Group Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 58,572 shares of the company’s stock after buying an additional 2,578 shares during the period. Daiwa Securities Group Inc.’s holdings in GE HealthCare Technologies were worth $4,529,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Cerity Partners LLC raised its holdings in GE HealthCare Technologies by 27.2% in the fourth quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock valued at $3,551,000 after buying an additional 9,809 shares during the period. Fifth Third Bancorp raised its holdings in GE HealthCare Technologies by 3.9% in the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after buying an additional 1,250 shares during the period. Douglas Lane & Associates LLC raised its holdings in GE HealthCare Technologies by 22.1% in the fourth quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock valued at $33,731,000 after buying an additional 79,073 shares during the period. Prio Wealth Limited Partnership raised its holdings in GE HealthCare Technologies by 25.1% in the fourth quarter. Prio Wealth Limited Partnership now owns 215,317 shares of the company’s stock valued at $16,648,000 after buying an additional 43,189 shares during the period. Finally, The Manufacturers Life Insurance Company raised its holdings in GE HealthCare Technologies by 34.9% in the third quarter. The Manufacturers Life Insurance Company now owns 341,769 shares of the company’s stock valued at $23,254,000 after buying an additional 88,384 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of several recent research reports. HSBC initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Morgan Stanley increased their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Citigroup increased their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and increased their price objective for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

GE HealthCare Technologies Stock Down 0.6 %

GEHC stock opened at $84.49 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $38.56 billion, a P/E ratio of 27.98, a PEG ratio of 2.96 and a beta of 0.94. The firm has a 50 day simple moving average of $88.74 and a 200-day simple moving average of $77.82.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. During the same quarter last year, the company earned $1.31 earnings per share. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.